Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Probe Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome

NCT00241215 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT00241215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00241215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Probe Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2003
Completion date
Not reported
Enrollment
132 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervicobrachial neuralgia, myofascial pain syndromes